PROMETHAZINE HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE bulk active fine chemical sources

Subscribe to access the full database, or Get Started Free
Vendor	Vendor Homepage	Vendor Sku	API Url
Starshine Chemical	⤷ Get Started Free	2023-05-5H02882	⤷ Get Started Free
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: November 17, 2025

Introduction

The pharmaceutical industry relies heavily on the global sourcing of Active Pharmaceutical Ingredients (APIs) to manufacture high-quality medications efficiently. For combination drugs such as Promethazine Hydrochloride and Phenylephrine Hydrochloride with Codeine Phosphate, ensuring a reliable supply chain of these APIs is vital for regulatory compliance, efficacy, and patient safety. This article details primary sources, manufacturing landscapes, and strategic considerations for sourcing these APIs globally.

Overview of APIs: Promethazine Hydrochloride and Phenylephrine Hydrochloride w/ Codeine Phosphate

Promethazine Hydrochloride is an antihistamine frequently used for allergies, nausea, and motion sickness. Its synthesis involves complex chemical processes requiring high-purity intermediates, which are produced predominantly in China and India.

Phenylephrine Hydrochloride acts as a nasal decongestant, often combined with Codeine Phosphate, an opioid cough suppressant. The combination is used for symptomatic relief of cough with congestion. Its APIs have diverse sourcing options, with key production hubs in India, China, and Europe.

Codeine Phosphate, an opioid, is a controlled substance regulated in many jurisdictions, which influences source availability and manufacturing practices.

Global API Manufacturing Landscape

The API supply chain is concentrated in regions with advanced pharmaceutical manufacturing capabilities:

India: Known for large-scale, cost-effective API production, India hosts numerous WHO-GMP certified manufacturers specializing in antihistamines, decongestants, and opioids. Companies like Aurobindo, Sun Pharmaceutical, and Dr. Reddy’s are prominent.
China: Dominates the API market due to robust manufacturing capacity, often providing bulk APIs at competitive prices. Key Chinese manufacturers such as Zhejiang Huahai Pharmaceutical and Shanghai SSIP Co. are significant suppliers.
Europe & North America: While strict regulatory standards make these regions less dominant in bulk Asia-origin APIs, certain high-quality APIs are sourced from European manufacturers such as Boehringer Ingelheim and licensed producers within North America.
Regulatory Influences: Stringent controls, especially for codeine, impact sourcing options, requiring suppliers to comply with local and international regulations (e.g., FDA, EMA, WHO).

Promethazine Hydrochloride API Sources

Manufacturers and Suppliers

India: Multiple suppliers with GMP-certified facilities, including companies like Aurobindo Pharma and Mylan. These manufacturers produce bulk promethazine HCl exported globally.
China: Zhejiang Huahai Pharmaceutical exports promethazine APIs, leveraging extensive chemical synthesis capabilities. Their supply quality is validated through international standards.
Europe & North America: Fewer manufacturers, primarily for high-grade APIs, due to strict regulatory requirements. Manufacturers such as MilliporeSigma provide specialized APIs under strict quality controls.

Key Considerations

Quality control and compliance with pharmacopoeia standards (USP, EP, JP) are critical.
Long-term contractual relationships ensure API supply stability amid rising global demand.

Phenylephrine Hydrochloride API Sources

Manufacturers and Suppliers

India: Known for producing phenylephrine HCl with extensive export volumes, primarily via companies like Sanofi, Sun Pharma, and Alembic.
China: Offers bulk phenylephrine APIs with competitive pricing, with Zhejiang Huahai and other Chinese firms remaining significant contributors.
Europe: European suppliers focus mainly on high-purity APIs for regulated markets, often with Quality-by-Design (QbD) manufacturing processes.

Implications for Source Selection

Due to the wide availability, Indian and Chinese APIs for phenylephrine are the most accessible.
Ensuring APIs meet regulatory standards is vital, especially for markets with rigorous pharmacopoeia compliance.

Codeine Phosphate: Controls and Sourcing Nuances

Control Regulations

As a controlled substance, codeine phosphate sourcing involves compliance with local regulations such as the DEA in the US, EMA in Europe, and other governing bodies.
Many manufacturers in India and China produce codeine API, but their supply is subject to strict licensing and record-keeping.

Source Reliability and Alternatives

Some countries restrict or ban codeine exports, prompting pharmaceutical companies to explore alternative suppliers or formulary substitutions.
Contract manufacturing organizations (CMOs) often navigate complex regulatory landscapes for codeine API, emphasizing the importance of verified supply chains.

Key Sourcing Strategies

Due Diligence and Qualification: Verify manufacturing certifications (GMP, ISO, WHO-GMP), quality audit records, and compliance history.
Supplier Diversification: Reduce dependency on single-source suppliers to mitigate risks associated with supply disruptions or regulatory changes.
Price and Lead Time Negotiation: Balance cost-effectiveness with quality assurance, considering geopolitical and logistical factors.
Regulatory Compliance: Choose suppliers with proven track records in regulatory adherence, especially for controlled substances like codeine.
Long-term Partnerships: Establish collaborations with reputable manufacturers to ensure reliable supply and streamline regulatory filings.

Challenges in API Sourcing

Regulatory Shifts: Policy changes, especially for controlled substances, can disrupt supply chains.
Quality Variability: Differences in manufacturing practices can lead to variability in API purity and stability.
Supply Chain Disruptions: Global events, such as pandemics or geopolitical tensions, impact manufacturing and logistics.
Cost Fluctuations: Price volatility in raw materials and shipping costs influence sourcing decisions.

Conclusion

The sourcing of Promethazine Hydrochloride, Phenylephrine Hydrochloride w/ Codeine Phosphate APIs involves navigating complex regulatory environments and diverse manufacturing landscapes. Indian and Chinese manufacturers dominate the supply of these APIs, offering cost-effective and high-volume options that meet international quality standards. Strategic sourcing requires diligent supplier qualification, regulatory compliance, and supply chain diversification to ensure consistent availability of high-quality APIs vital for pharmaceutical manufacturing.

Key Takeaways

India and China are primary global sources for Promethazine and Phenylephrine APIs, with established quality and capacity.
Controlled substances like codeine demand strict regulatory adherence, influencing sourcing flexibility and procedures.
Supplier qualification, compliance, and diversification are vital to mitigate risks associated with supply disruptions.
Priority should be given to manufacturers with proven GMP compliance and regulatory acceptance in target markets.
Long-term partnerships and continuous quality audits enhance supply stability and product integrity.

FAQs

1. What are the main advantages of sourcing APIs from India and China?
India and China offer cost-effective manufacturing, extensive capacity, and proven quality standards, making them primary sources for bulk APIs globally.

2. How does regulatory compliance impact API sourcing?
Regulatory standards such as GMP, FDA, and EMA requirements influence supplier qualification, documentation, and ongoing compliance, especially crucial for controlled substances like codeine.

3. What challenges are associated with sourcing codeine phosphate APIs?
Codeine phosphate is a controlled substance, subject to strict export regulations, licensing requirements, and potential supply restrictions, which can cause procurement delays.

4. Why is supplier diversification important in API sourcing?
Diversifying suppliers reduces dependency on single sources, minimizes risks from geopolitical issues, regulatory changes, and supply chain disruptions.

5. What considerations should be made when selecting an API manufacturer?
Beyond price, factors include regulatory certification, quality control processes, manufacturing capacity, compliance history, and logistical capabilities.

Sources

[1] GlobalData Healthcare. "API Manufacturing and Supply Chain Trends," 2022.
[2] WHO Geneva. "Guidelines on Good Manufacturing Practices," 2017.
[3] U.S. Drug Enforcement Administration. "Controlled Substances Act," 2023.
[4] IQVIA. "API Market Analysis," 2022.
[5] European Medicines Agency. "Regulations for Active Substance Manufacturing," 2023.

Bulk Pharmaceutical API Sources for PROMETHAZINE HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE